Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
CAUD - Collective Audience Inc - Stock Price Chart
TickerCAUD [NASD]
CompanyCollective Audience Inc
CountryUSA
IndustrySoftware - Application
Market Cap9.81MEPS (ttm)-1.01
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.34EPS Q/Q-338.22%
Dividend-Sales Q/Q-
Insider Own69.14%Inst Own1.80%
Insider Trans-2.66%Inst Trans3.09%
Short Float6.35%Earnings-
Analyst Recom-Target Price-
Avg Volume334.87K52W Range0.37 - 38.40
Abri SPAC focuses on mergers, share exchange, asset acquisition, stock purchase, and business combinations with one or more businesses. Abri SPAC was founded in 2021 and was headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Abri Ventures I, LLC10% OwnerApr 08 '24Sale0.55600,000330,0001,013,078Apr 10 04:15 PM
BORDES PETER A JRChief Executive OfficerJan 16 '24Buy0.9420,00018,8001,211,429Jan 17 11:05 AM
Watt Nadine IDirectorDec 28 '23Buy1.5010,00014,98810,000Dec 29 04:01 PM
SUEN BRENTDirectorDec 26 '23Buy1.2923,33430,1011,079,578Dec 26 05:29 PM
Duncan Denis J.DirectorDec 26 '23Buy1.2420,00024,80020,000Dec 27 05:29 PM
DCPH - Deciphera Pharmaceuticals Inc - Stock Price Chart
TickerDCPH [NASD, RUT]
CompanyDeciphera Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap2.07BEPS (ttm)-2.29
P/E-EPS this Y4.44%
Forward P/E-EPS next Y23.22%
PEG-EPS past 5Y4.07%
P/S12.70EPS next 5Y21.00%
P/B5.79EPS Q/Q9.42%
Dividend-Sales Q/Q32.88%
Insider Own38.85%Inst Own62.71%
Insider Trans-0.33%Inst Trans1.37%
Short Float11.45%EarningsFeb 06/b
Analyst Recom2.00Target Price25.38
Avg Volume516.13K52W Range9.90 - 17.73
Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kelly Thomas PatrickChief Financial OfficerFeb 16 '24Sale15.623,01047,00980,350Feb 20 04:05 PM
Sherman Matthew LEVP & Chief Medical OfficerFeb 16 '24Sale15.622,61540,840108,739Feb 20 04:06 PM
Pitman JamaSVP, Chief Development OfficerFeb 16 '24Sale15.622,26735,40568,031Feb 20 04:05 PM
Martin Daniel C.Chief Commercial OfficerFeb 16 '24Sale15.622,26735,40555,118Feb 20 04:05 PM
Kelly Thomas PatrickChief Financial OfficerJan 16 '24Sale14.472,43535,23466,085Jan 18 04:15 PM
MULN - Mullen Automotive Inc - Stock Price Chart
TickerMULN [NASD]
CompanyMullen Automotive Inc
CountryUSA
IndustryAuto Manufacturers
Market Cap32.23MEPS (ttm)-2356.61
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y44.05%
P/S87.10EPS next 5Y-
P/B0.14EPS Q/Q99.75%
Dividend-Sales Q/Q-
Insider Own1.68%Inst Own11.68%
Insider Trans0.00%Inst Trans-
Short Float20.95%Earnings-
Analyst Recom-Target Price5.17
Avg Volume905.15K52W Range2.36 - 2250.00
Mullen Automotive Inc. operates as an electric vehicle company, which engages in the manufacture of passenger electric vehicles and commercial vehicles. It operates through the Bollinger and Mullen/ELMS segments. The company was founded by David Michery on April 20, 2010 and is headquartered in Brea, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Michery DavidCEO, PresidentAug 16 '23Buy0.98102,040100,4281,322,083Aug 17 06:11 AM
HWH - HWH International Inc. - Stock Price Chart
TickerHWH [NASD]
CompanyHWH International Inc.
CountryUSA
IndustryLeisure
Market Cap41.39MEPS (ttm)0.06
P/E39.87EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.64EPS Q/Q-453.70%
Dividend-Sales Q/Q-
Insider Own86.76%Inst Own9.29%
Insider Trans0.00%Inst Trans5.28%
Short Float5.37%Earnings-
Analyst Recom-Target Price-
Avg Volume862.18K52W Range0.75 - 15.04
HWH International, Inc. operates as a lifestyle business through a membership model. It enables home-based people in the new GIG economy to create lasting wealth. Its segments include HWH Marketplace, Hapi Cafe, Hapi Travel Destinations, and Hapi Wealth Builder. HWH Marketplace offers discounted sale of certain products, manufactured by affiliate company, Sharing Services Global Corp., to members. Hapi Cafe offers location-based social experiences where members can build a sense of community with like-minded customers with a potential interest in the same products. Hapi Travel Destinations aims to offer exclusive access to unpublished rates and discounts on air travel, cruises, car rentals, hotels, and resorts for members. Hapi Wealth Builder is exploring options of providing services to members through educational materials and seminars aimed at various types of investing opportunities. The company is headquartered in Bethesda, MD.
SINT - SINTX Technologies Inc - Stock Price Chart
TickerSINT [NASD]
CompanySINTX Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap6.79MEPS (ttm)-2.02
P/E-EPS this Y97.37%
Forward P/E-EPS next Y80.00%
PEG-EPS past 5Y79.20%
P/S2.58EPS next 5Y-
P/B0.03EPS Q/Q97.41%
Dividend-Sales Q/Q17.91%
Insider Own0.02%Inst Own3.76%
Insider Trans0.00%Inst Trans-4.52%
Short Float0.45%Earnings-
Analyst Recom3.00Target Price10.50
Avg Volume28.36M52W Range0.02 - 1.82
SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.
BTOG - Bit Origin Ltd - Stock Price Chart
TickerBTOG [NASD]
CompanyBit Origin Ltd
CountryUSA
IndustryCapital Markets
Market Cap24.22MEPS (ttm)-10.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.42EPS next 5Y-
P/B2.73EPS Q/Q-62.83%
Dividend-Sales Q/Q40.16%
Insider Own11.31%Inst Own0.65%
Insider Trans0.00%Inst Trans-
Short Float6.47%Earnings-
Analyst Recom-Target Price-
Avg Volume504.02K52W Range1.25 - 9.71
Bit Origin Ltd. operates as an emerging growth company which engages in crypto mining business. The firm also actively deploys blockchain technologies, alongside diversified expansion strategies. It has operations in the United States, Canada, and China. The company was founded on January 23, 2018 and is headquartered in New York, NY.
SEPA - SEP Acquisition Corp - Stock Price Chart
TickerSEPA [NASD]
CompanySEP Acquisition Corp
CountryUSA
IndustryShell Companies
Market Cap70.21MEPS (ttm)-0.41
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B7.04EPS Q/Q-284.37%
Dividend-Sales Q/Q-
Insider Own91.15%Inst Own5.00%
Insider Trans0.00%Inst Trans-
Short Float0.35%Earnings-
Analyst Recom-Target Price-
Avg Volume2.21K52W Range8.20 - 17.00
SEP Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on March 1, 2021 and is headquartered in Houston, TX.
PAHC - Phibro Animal Health Corp. - Stock Price Chart
TickerPAHC [NASD, RUT]
CompanyPhibro Animal Health Corp.
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap667.44MEPS (ttm)0.37
P/E45.10EPS this Y-8.88%
Forward P/E13.35EPS next Y11.97%
PEG18.79EPS past 5Y-12.91%
P/S0.68EPS next 5Y2.40%
P/B2.46EPS Q/Q-82.36%
Dividend2.91%Sales Q/Q2.17%
Insider Own50.06%Inst Own51.03%
Insider Trans0.00%Inst Trans-1.80%
Short Float3.10%EarningsMay 08/a
Analyst Recom4.25Target Price10.75
Avg Volume143.28K52W Range9.40 - 15.96
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
PHG - Koninklijke Philips N.V. ADR - Stock Price Chart
TickerPHG [NYSE]
CompanyKoninklijke Philips N.V. ADR
CountryNetherlands
IndustryMedical Devices
Market Cap24.67BEPS (ttm)-0.54
P/E-EPS this Y11.82%
Forward P/E15.55EPS next Y17.20%
PEG-EPS past 5Y-
P/S1.26EPS next 5Y15.56%
P/B1.86EPS Q/Q-
Dividend3.25%Sales Q/Q5.04%
Insider Own0.00%Inst Own7.60%
Insider Trans-Inst Trans-26.40%
Short Float0.42%EarningsApr 29/b
Analyst Recom3.38Target Price22.00
Avg Volume1.05M52W Range17.75 - 24.27
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
IBRX - ImmunityBio Inc - Stock Price Chart
TickerIBRX [NASD, RUT]
CompanyImmunityBio Inc
CountryUSA
IndustryBiotechnology
Market Cap6.32BEPS (ttm)-1.13
P/E-EPS this Y35.22%
Forward P/E-EPS next Y30.20%
PEG-EPS past 5Y1.17%
P/S10194.91EPS next 5Y-1.70%
P/B-EPS Q/Q-29.72%
Dividend-Sales Q/Q90.41%
Insider Own79.68%Inst Own8.46%
Insider Trans0.00%Inst Trans10.14%
Short Float40.05%Earnings-
Analyst Recom2.00Target Price7.50
Avg Volume5.41M52W Range1.25 - 7.74
Apr-25-24 12:03AM ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIVA in Lung Cancer (Business Wire) +6.02%
Apr-23-24 04:55PM ImmunityBio's bladder cancer therapy wins FDA approval (Yahoo Finance Video) +11.13%
Apr-22-24 09:56PM ImmunityBio Announces FDA Approval of ANKTIVA, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (Business Wire) -6.26%
Apr-19-24 11:02AM 12 Most Shorted Stocks in 2024 (Insider Monkey) +7.33%
Mar-19-24 09:53PM IBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
Mar-14-24 08:45AM Biotech's Role in Addressing the Pancreatic Cancer Emergency (PR Newswire)
Mar-06-24 09:00AM NIAID-Sponsored Study Shows N-803 Combined with Neutralizing Antibodies Could Lead to Sustained HIV Viral Control After Discontinuation of Antiretroviral Therapy (Business Wire) +5.39%
Mar-05-24 09:00AM N-803 Combined with Natural Killer Cells Showed Potential to Reduce HIV Viral Load in HIV Positive Subjects; Part of HIV Cure Study (Business Wire)
Feb-21-24 09:00AM ImmunityBio Announces Full Accrual of First Two Phases of Cancer Vaccine Trial in Participants with Lynch Syndrome and Initiation of Randomized Controlled Phase of the Trial (Business Wire)
Feb-05-24 09:00AM ImmunityBio Quality-of-Life Study in BCG-Unresponsive Bladder Cancer Trial Indicates Improved Physical Function in the 71% Complete Responders Suggesting a Favorable Risk-Benefit Ratio for N-803 Plus BCG (Business Wire)
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adcock RichardCEO & PresidentFeb 05 '24Option Exercise0.0083,3340286,303Feb 06 09:14 PM
LAUER REGAN JChief Accounting OfficerJan 31 '24Option Exercise0.0032,8720107,804Feb 02 07:32 PM
Sachs David C.Chief Financial OfficerJan 31 '24Option Exercise0.0070,7450212,673Feb 02 07:33 PM
Simon Barry J.DirectorJan 31 '24Option Exercise0.0057,20003,145,855Feb 02 07:38 PM
Adcock RichardCEO & PresidentDec 31 '23Option Exercise0.0034,4830220,065Jan 03 09:40 PM
1234561020